Arbor Pharmaceuticals, LLC and Debiopharm International SA Announce U.S. FDA Approval for Triptodur Read more
CordenPharma & GE Healthcare Offer Unique End-to-End Solution to Accelerate Oligonucleotide Drug Development Read more
Trovagene Announces Manufacturing Agreement with NerPharMa for Supply of PCM-075 for AML Trial Read more
Glytec Receives Five Additional Patent Allowances for its Diabetes Therapy Management Software Read more
FDA Approves VNS Therapy Treatment for Drug-Resistant Epilepsy in Children as Young as Four Years Old Read more